Full Text View
Tabular View
No Study Results Posted
Related Studies
Campath-1H and Allogeneic Blood Stem Cell Transplantation for Lymphoid Malignancies
This study has been terminated.
Study NCT00038883   Information provided by M.D. Anderson Cancer Center
First Received: June 5, 2002   Last Updated: June 23, 2005   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Leukemia, Lymphocytic, Chronic
Leukemia, Lymphocytic, Acute
Lymphoma, Low-Grade
Lymphoma, T-Cell
Lymphoma, B-Cell
Additional conditions recognized in this trial
Leukemia
Leukemia, B-Cell
Leukemia, Lymphocytic, Chronic, B-Cell
Leukemia, Lymphoid
Lymphoma
Lymphoma, Non-Hodgkin
Neoplasms
Precursor Cell Lymphoblastic Leukemia-Lymphoma
More general conditions related to this trial
Immune System Diseases
Immunoproliferative Disorders
Lymphatic Diseases
Lymphoproliferative Disorders
Neoplasms by Histologic Type
Interventions listed in this trial
Campath-1H
Additional drug interventions recognized in this trial
Alemtuzumab
More general drug interventions related to this trial
Antineoplastic Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
M.D. Anderson Cancer Center


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services